DON M BAILEY
CIK 1223697 · See Remarks · last filed 2024-07-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.72M
Companies
9
Total Filings
88
Lifetime Open-Market Net
-$95.61M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LCTX | Director | 158,801 | $1.27 | $201.7K | $100.0K | 6 | 2024-07-03 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | Director | 88,235 | — | — | $0 | 2 | 2018-06-25 |
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Director | 247,001 | $3.20 | $790.4K | $0 | 3 | 2017-06-19 |
| Asterias Biotherapeutics, Inc. (AST.WS) Delisted | Director | 88,235 | — | — | $299.1K | 2 | 2017-04-03 |
| Keenova Therapeutics plc (MNK) Delisted | Director | 227,952 | $0.34 | $77.5K | -$39.07M | 10 | 2016-03-18 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | See Remarks | 239,437 | — | — | -$57.24M | 43 | 2014-08-15 |
| STAA | Director | 123,937 | $28.37 | $3.52M | $303.9K | 13 | 2013-05-16 |
| QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | PRESIDENT & CEO | 0 | — | — | $0 | 5 | 2008-02-19 |
| COMARCO INC (CMRO) Delisted | Chairman of the Board | 66,095 | — | — | $0 | 2 | 2007-06-12 |
Recent Filings · Page 2 of 9
88 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-10-19 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-08-30 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-05-17 | Asterias Biotherapeutics, Inc. (AST.WS) Delisted | Buy (P) | +88,235 | $299.1K | EDGAR |
| 2016-03-18 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −458 | -$25.5K | EDGAR |
| 2016-03-01 | Asterias Biotherapeutics, Inc. (AST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-14 | Keenova Therapeutics plc (MNK) Delisted | Mixed | — | -$4.91M | EDGAR |
| 2015-04-14 | Keenova Therapeutics plc (MNK) Delisted | Mixed | — | -$4.03M | EDGAR |
| 2015-03-23 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +3,002 | -$79.5K | EDGAR |
| 2015-03-17 | Keenova Therapeutics plc (MNK) Delisted | Mixed | — | -$3.86M | EDGAR |
| 2015-02-17 | Keenova Therapeutics plc (MNK) Delisted | Mixed | — | -$3.52M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.